Kevin M. Picardat

Array ( [id] => 699176 [patent_doc_number] => 07067474 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-27 [patent_title] => 'Agents for treating human illnesses based on β-catenin, and the production and use thereof' [patent_app_type] => utility [patent_app_number] => 09/641104 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5732 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067474.pdf [firstpage_image] =>[orig_patent_app_number] => 09641104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408344 [patent_doc_number] => 07285653 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-23 [patent_title] => 'Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis' [patent_app_type] => utility [patent_app_number] => 10/069353 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9186 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285653.pdf [firstpage_image] =>[orig_patent_app_number] => 10069353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271715 [patent_doc_number] => 06653460 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Voltage-gated calcium channel antagonist and method' [patent_app_type] => B1 [patent_app_number] => 09/640957 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 29 [patent_no_of_words] => 21901 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653460.pdf [firstpage_image] =>[orig_patent_app_number] => 09640957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 935447 [patent_doc_number] => 06974796 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-13 [patent_title] => 'Therapeutic compositions for treatment of a damaged tissue' [patent_app_type] => utility [patent_app_number] => 09/639859 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11383 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974796.pdf [firstpage_image] =>[orig_patent_app_number] => 09639859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504718 [patent_doc_number] => 06465621 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Compounds' [patent_app_type] => B1 [patent_app_number] => 09/631548 [patent_app_country] => US [patent_app_date] => 2000-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11947 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465621.pdf [firstpage_image] =>[orig_patent_app_number] => 09631548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 785346 [patent_doc_number] => 06989371 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-24 [patent_title] => 'Bombesin analogs for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 09/630333 [patent_app_country] => US [patent_app_date] => 2000-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7489 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989371.pdf [firstpage_image] =>[orig_patent_app_number] => 09630333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065787 [patent_doc_number] => 06846913 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Crude extract from Viscum album coloratum, and proteins and lectins isolated therefrom' [patent_app_type] => utility [patent_app_number] => 09/627165 [patent_app_country] => US [patent_app_date] => 2000-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 36 [patent_no_of_words] => 15156 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846913.pdf [firstpage_image] =>[orig_patent_app_number] => 09627165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311572 [patent_doc_number] => 06613745 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Therapeutic molecules derived from snake venom' [patent_app_type] => B1 [patent_app_number] => 09/530799 [patent_app_country] => US [patent_app_date] => 2000-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9302 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613745.pdf [firstpage_image] =>[orig_patent_app_number] => 09530799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278960 [patent_doc_number] => 06641820 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Clostridial toxin derivatives and methods to treat pain' [patent_app_type] => B1 [patent_app_number] => 09/625098 [patent_app_country] => US [patent_app_date] => 2000-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14688 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641820.pdf [firstpage_image] =>[orig_patent_app_number] => 09625098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1400602 [patent_doc_number] => 06537968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Treatment of lupus erythematosus' [patent_app_type] => B1 [patent_app_number] => 09/624442 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1740 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537968.pdf [firstpage_image] =>[orig_patent_app_number] => 09624442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1031135 [patent_doc_number] => 06878687 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-12 [patent_title] => 'Protein HMAAD57' [patent_app_type] => utility [patent_app_number] => 09/621011 [patent_app_country] => US [patent_app_date] => 2000-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73684 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878687.pdf [firstpage_image] =>[orig_patent_app_number] => 09621011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1181487 [patent_doc_number] => 06737408 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-18 [patent_title] => 'Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm' [patent_app_type] => B1 [patent_app_number] => 09/618361 [patent_app_country] => US [patent_app_date] => 2000-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11016 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 326 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737408.pdf [firstpage_image] =>[orig_patent_app_number] => 09618361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202801 [patent_doc_number] => 06720304 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Conjugate comprising a folic acid antagonist and a carrier' [patent_app_type] => B1 [patent_app_number] => 09/423710 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2705 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720304.pdf [firstpage_image] =>[orig_patent_app_number] => 09423710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1582228 [patent_doc_number] => 06423829 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Nitrobenzylmercaptopurineriboside (NBMPR)-insensitive, equilibrative, nucleoside transport protein, nucleic acids encoding the same and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/611781 [patent_app_country] => US [patent_app_date] => 2000-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31044 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423829.pdf [firstpage_image] =>[orig_patent_app_number] => 09611781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416398 [patent_doc_number] => 06511959 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Use of calcium-activated neutral protease (CANP) inhibitors in pharmaceutical preparations' [patent_app_type] => B1 [patent_app_number] => 09/610995 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4912 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511959.pdf [firstpage_image] =>[orig_patent_app_number] => 09610995 [rel_patent_id] =>[rel_patent_doc_number] =>)